Lv Meijun, Wang Lishan
1Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine , Shanghai , People's Republic of China.
Exp Lung Res. 2015 Mar;41(2):74-83. doi: 10.3109/01902148.2014.971472. Epub 2014 Dec 16.
The aim of this study was to investigate the molecular mechanism of lung cancer among nonsmoking Taiwan females.
By using the GSE19804 microarray data accessible from Gene Expression Omnibus (GEO) database, we identified differentially expressed genes (DEGs) between nonsmoking female lung cancer patients and healthy controls (!logFC! >1.5 and p-value < 0.05). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene ontology (GO) enrichment analysis was performed using Database for Annotation, Visualization and Integrated Discovery (DAVID). The Search Tool for the Retrieval of Interacting Genes (STRING) tool was utilized to build a protein-protein interaction (PPI) network, followed by the construction of a transcriptional regulatory network based on Transcription factor (TRANSFAC) database.
As a result, 320 DEGs were identified between nonsmoking female patients with lung cancer and healthy controls. Pathway enrichment analysis showed significantly enriched pathways such as extracellular matrix (ECM)-receptor interaction and peroxisome proliferator-activated receptor (PPAR) signaling pathway, both of which were enriched with genes COL11A1 (encoding collagen XI alpha-1 chain protein), COL1A1, cluster of differentiation 36(CD36). GO enrichment analysis found that DEGs were significantly related to chemotaxis, vasculature development and cell adhesion GO terms. IL-6 was the node of the PPI network. Critical transcription factors (TFs) including CCAAT/enhancer-binding protein delta (CEBPD) and Rel/NF-κB were also identified.
Our study revealed that ECM-receptor interaction, PPAR signaling pathways, and important biomolecules including COL11A1, COL1A1, CD36, IL-6, CEBPD, and Rel/NF-κB might be involved in lung cancer. This study might pave the way for the development and application of targeted therapeutics of lung cancer irrelevant to smoking.
本研究旨在探究台湾非吸烟女性肺癌的分子机制。
通过使用从基因表达综合数据库(GEO)获取的GSE19804芯片数据,我们鉴定了非吸烟女性肺癌患者与健康对照之间的差异表达基因(DEGs)(|logFC|>1.5且p值<0.05)。使用注释、可视化与整合发现数据库(DAVID)进行京都基因与基因组百科全书(KEGG)通路和基因本体(GO)富集分析。利用检索相互作用基因的搜索工具(STRING)构建蛋白质-蛋白质相互作用(PPI)网络,随后基于转录因子(TRANSFAC)数据库构建转录调控网络。
结果显示,在非吸烟女性肺癌患者与健康对照之间鉴定出320个DEGs。通路富集分析表明细胞外基质(ECM)-受体相互作用和过氧化物酶体增殖物激活受体(PPAR)信号通路等显著富集的通路,这两条通路均富含基因COL11A1(编码胶原蛋白XIα-1链蛋白)、COL1A1、分化簇36(CD36)。GO富集分析发现DEGs与趋化性、血管系统发育和细胞黏附GO术语显著相关。IL-6是PPI网络的节点。还鉴定出包括CCAAT/增强子结合蛋白δ(CEBPD)和Rel/NF-κB在内的关键转录因子(TFs)。
我们的研究表明,ECM-受体相互作用、PPAR信号通路以及包括COL11A1、COL1A1、CD36、IL-6、CEBPD和Rel/NF-κB在内的重要生物分子可能参与肺癌的发生。本研究可能为非吸烟相关肺癌的靶向治疗药物的开发与应用铺平道路。